Unum Group Q2 2021 Earnings Call Transcript

Quartr
Provided by Quartr
August 4, 2021

There are 11 speakers on the call.

Operator

Good day, everyone, and welcome to the Unum Group Second Quarter 2021 Earnings Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note that this event is being recorded. I would now like to turn the conference over to Tom White, Senior Vice President of Investor Relations.

Operator

Please go ahead, sir.

Speaker 1

Great. Thank you. Good morning, everyone, and welcome to the Q2 2021 earnings conference call for Unum. Our remarks today will include forward looking statements, which are statements that are not of current or historical fact. As a result, actual results might differ materially from results suggested by these forward looking statements.

Speaker 1

Information concerning factors that could cause results Differ appears in our filings with the Securities and Exchange Commission and are also located in the sections titled Cautionary Statement Regarding Forward Looking Statements And risk factors in our annual report on Form 10 ks for the fiscal year ended December 31, 2020, and our subsequently filed Form 10 Q. A presentation of the most directly comparable GAAP measures and reconciliations of any non GAAP financial measures included in today's presentation Can be found in our statistical supplement on our website in the Investors section. Yesterday afternoon, Unum reported 2nd quarter 2021 net income of $182,900,000 or $0.89 per diluted common share compared to $265,500,000 or $1.30 per diluted common share in the Q2 of 2020. Net income for the Q2 of 2021 included the after tax cost related to the early retirement of debt $53,200,000 or $0.26 per diluted common share, the after tax amortization of the cost reinsurance of $15,500,000 or $0.08 per diluted common share and after tax impairment loss On the right of use asset related to one of our operating leases for office space we are no longer using to support our general operations portfolio of $600,000 or $0.01 per diluted common share and the net tax expense related to a U.

Speaker 1

K. Tax rate increase of $24,200,000 or $0.12 per diluted common share. Net income in the Q2 of 20, including an after tax impairment loss on the right of use asset of $10,000,000 or $0.05 per diluted common share And a net after tax realized investment gain of $25,400,000 or $0.12 per diluted common share. So excluding these items, after tax adjusted operating income in the Q2 of 2021 was $286,200,000 or $1.39 per diluted common share compared to $250,100,000 or $1.23 per diluted common share in the year ago quarter. Participating in this morning's conference call are Unum's President and CEO, Rick McKenney, excuse me Chief Financial Officer, Steve Zabel and Chief Operating Officer, Mike Simons As well as Mark Till, who heads our Unum International Business and Tim Arnold, who heads our Colonial Life and Voluntary Benefits Businesses.

Speaker 1

And now I'll turn the call over to Rick for his opening comments. Thank you, Tom, and good morning, everyone. I am very pleased with our 2nd quarter results. We showed a 13% increase year over year and after tax adjusted operating income to $1.39 per share. These improved results were driven in large part by the significant decline in COVID related mortality this quarter and by excellent performance in our investment portfolio.

Speaker 1

Given our strong second quarter results, we're raising our outlook for full year 2021 growth and after tax adjusted operating income per share to a decline of approximately 1% to 3% compared to our previous outlook of a decline of 5% to 6%. We believe we're making good progress Returning to our pre pandemic levels of profitability and margins over the coming quarters with the trajectory of that improvement dependent on the developing trends in COVID and the Delta variant. Embedded in our expectations is that COVID mortality will improve, but only slightly in the 3rd 4th quarters. In many ways, results for this quarter played out in line with our expectations, with declining mortality impacts, solid underlying premium trends and further strengthening of our healthy capital position. This quarter was also highlighted with some areas of positive upside relative to our expectations.

Speaker 1

Most notably, we saw continued excellent returns from our alternative investment portfolio, which is benefiting from the strong financial markets and growth in the economy. We also saw a record level of quarterly operating income for Colonial Life, along with an impressive recovery in sales. And rounding it out, we had favorable underlying benefits experience from our Closed Block business lines, both Long Term Care and the Closed Disability Block. We'll cover these positive trends in detail throughout our comments this morning. In addition to the positive trends we saw this quarter, I am pleased that our indicators continue to support Our expectation of generating slightly positive growth in premium income in our core business segments this year, with further improvement expected into 2022.

Speaker 1

Sales trends are emerging in line with our expectations in our primary business lines within Unum US And Colonial Life showed very strong results this quarter with over a 50% increase from the year ago quarter, a good indicator of consumer interest in the basic It also highlights that the agency model of Colonial Life is quite resilient as it saw some of the most pronounced in the early stages of the pandemic. In addition to sales trends, we remain very encouraged with the strong levels of persistency we're seeing across the majority of our business, which provide a solid base to grow. Finally, we're seeing a pickup in natural growth, primarily from higher wages in many sectors of the economy, As we continue to build back premium income that was impacted by the sharp spike in unemployment in the first half of twenty twenty. The environment we are seeing today is quite good for our core business. We often talk about wage inflation, but you have to add to the mix, There is renewed recognition for the need to prepare for the unexpected.

Speaker 1

And in a competitive world for talent, employers are looking to ensure as they have competitive benefits package for their current and prospective employees. Turning to our capital position at quarter end, It remained very healthy as well, with holding company cash at $1,700,000,000 and weighted average risk based capital for our traditional U. S. Insurance companies at 3 75%. Both of these measures are in excess of our targets and provide substantial flexibility for us going forward.

Speaker 1

Additionally, this quarter, we successfully completed a 30 year debt issue and redeemed a shorter high coupon maturity, enabling us to further extend our debt stack, while reducing the overall coupon. Leverage remains approximately 28% 26% and provides further capital flexibility for us. This strong capital position creates options for us as we look to create value for our shareholders. Our deployment strategy will first focus on continuing to invest in the growth of our core business segments, both organically and through capability driven acquisitions. We like our position in the employee benefits market and putting money to work to grow our core franchise is where we are focused.

Speaker 1

We also expect to be consistent in returning capital to shareholders through dividends, which will increase by 5.3% with a dividend to be paid this month. We do have funds in excess of these needs. So as we look to the future, we are constantly evaluating how to best deploy or hold on to this capital. A key question is how we can use these funds to lessen the challenge to our current share price from the overhang of our legacy LTC block. Return of capital to shareholders remains an important option for us, but we are also considering prefunding a portion of the PDR.

Speaker 1

Our goal is to help reduce the LTC discount in our stock. And in the future, this funding would be utilized in any risk transfer transaction that we explore on a portion of this block, should that become an option for us. While we are clearly optimistic looking forward, we do see areas of our business that continue to be impacted by the pandemic. Results in our short term disability line and leave services continue to be impacted by COVID related claims, which remains stubbornly high. The Group Life and AD and D business within Unum US returned to profitability in the 2nd quarter After recording losses in the previous two quarters, as COVID related mortality in the U.

Speaker 1

S. Declined materially from the peak levels experienced late last year through the early months of 2021. What we are watching now is that the Delta variant is impacting a younger unvaccinated population That has different dynamics from what we have seen to date from COVID-nineteen. Recently updated estimates for COVID related mortality for the Q3 and second half of twenty twenty one are pointing to persistently high counts and only a marginal improvement relative to the Q2. We continue to watch these trends closely and are reflecting them in our own plans.

Speaker 1

There is room for optimism though as we have started to see employers looking at the role that they might play in getting more of the population vaccinated. As we look at growth in our enterprise, the steps we're taking we've taken to run our business more efficiently have freed up funds that are we're reinvesting in new products and capabilities that tackle some of today's critical business workplace challenges. During the quarter, we launched our new total leave and behavioral health solutions, And we've logged our 1st sales for both offerings. On the digital front, platforms like MyUnum and Colonial Life's improved portal Are steadily providing more self-service real time capabilities for clients and customers. A new technology we're testing will enhance the digital enrollment experience, Automate processes that allow people to interact with us in new ways.

Speaker 1

Equally important is the work we're doing to strengthen our culture and engage our employees across the enterprise. We've taken steps during the quarter to accelerate and expand our inclusion and diversity journey. And we broaden the scope of our social justice fund to support even more groups facing discrimination. These and many other efforts help place Unum among the points of light, Civic 50 and Enforce Best Employers for Diversity, Best Employers for Women and Best Employers for New Graduates. We also happy to receive another perfect score on the Human Rights Campaigns Corporate Equality Index and to be named a Best Place to Work for Disability Inclusion.

Speaker 1

These efforts and accomplishments reflect the strong culture we have built. We are proud of how it has helped us endure through the challenges of the past year and a half and how the engagement of our team will propel us going forward. Now I'll ask Steve to cover the details of the second quarter results. Steve?

Speaker 2

Yes. Thank you, Rick, and good morning, everyone. As I discuss our Q2 financial results this morning, I will primarily focus on analysis of our Q2 results Relative to the Q1 of 2021, which will allow us to show how the company's business lines are recovering from the pandemic. I'll start with the Unum U. S.

Speaker 2

Segment, which reported adjusted operating income for the Q2 of $179,300,000 compared to $115,700,000 in the Q1. These results improved significantly due to the improvement in COVID related mortality In our Group Life business line, which I'll provide more detail on in a moment. We also saw improved operating income from the supplemental voluntary line, While income in the group disability line declined compared to the Q1. Within the Unum U. S.

Speaker 2

Segment, the group disability line reported operating income of $59,900,000 in the 2nd quarter compared to $64,100,000 in the 1st quarter. The primary driver of the change was lower net investment which largely resulted from a lower level of bond calls. Premium income was generally consistent between the two quarters and on a year over year basis Increased 1.1 percent. The group disability benefit ratio for the 2nd quarter was 74.7%, which is consistent with the Q1 benefit ratio of 74.8%. We feel the benefit ratio will likely remain at this level over the near term Due to the impacts we are seeing from COVID in the Delta variant, which we now believe will likely persist through the second half of the year.

Speaker 2

Adjusted operating income for Unum US Group Life and AD and D showed a sharp improvement in the 2nd quarter to income of $5,200,000 compared to a loss of $58,300,000 in the Q1. This improvement is consistent with our expectation And largely explained by the significant reduction in COVID related mortality in the U. S, which declined from approximately 200,000 nationwide observed deaths in the first order to approximately 52,000 in the second quarter. We estimate that we incurred approximately 800 excess claims from COVID in the second quarter compared to an estimate of 2,050 COVID claims in the Q1. Our average size of claim increased in the 2nd quarter by approximately 10% As we experienced a mix shift to a more younger working age policyholders who typically have higher benefit amounts, non COVID related mortality had little impact on results This quarter relative to the Q1 as lower incidence was offset by higher average point size.

Speaker 2

Now looking ahead to the 3rd quarter, our current for nationwide COVID related mortality of approximately 40,000 compared to approximately 52,000 experienced in the 2nd quarter. Assuming the shift in the mix continues to more younger working aged individuals with a continued higher average benefit amount, We would estimate 3rd quarter group life operating income to show a modest improvement over 2nd quarter results to approximately $15,000,000 We are closely watching the impacts emerging from the COVID variance, which have led to increasing estimates for second half mortality expectations. Now shifting to the Unum U. S. Supplemental and voluntary lines, we saw an improved quarter with adjusted operating income of $114,200,000 in the second Order compared to $109,900,000 in the Q1.

Speaker 2

Looking at the 3 primary business lines, first, we remain very pleased with the performance of the individual disability recently issued block of business, both in the second disability recently issued block of business both in the Q2 and throughout the pandemic. Though the benefit ratio did increase to 48.4 in the 2nd quarter from 42.4% in the Q1. It continues to perform quite well compared to our pre pandemic experience as new claim incidence trends and recovery levels remain favorable. The voluntary benefits line recorded a strong level of income as well. The benefit ratio increased in the Q2 relative to the Q1, though it did remain consistent with the pre pandemic results.

Speaker 2

The benefit ratio in the group critical illness line increased offsetting the improved experience in the lifelines of business. And then finally, utilization in the dental and vision line was higher this quarter as was the average cost per procedure pushing the benefit ratio Showed to 77.1 percent in the 2nd quarter compared to 73.2% in the 1st quarter. Dental and vision utilization has been volatile since the significant decline in utilization we did experience in the Q2 of 2020. Sales for Unum US in total declined 3.1% in the 2nd quarter on a year over year basis compared to the decline of 10.3% in the Q1. For the employee benefit lines, which include LTD, STD, Group Life, AD and D and stop loss, total sales declined by 3.1% this quarter.

Speaker 2

We saw good activity and results in the core markets for group disability and group life, While large case sales were down year over year, we are seeing a good level of quote activity in the group markets, which is back to pre pandemic levels. Sales trends in our supplemental and voluntary lines showed similar improvement in the 2nd quarter relative to the Q1. For this quarter, total sales declined 3.1% year over year compared to the 22.3% decline in the Q1. Our recently issued individual disability sales increased 4.9% and dental and vision sales increased 2.4% year over year. Voluntary benefit sales were down 7% in the quarter, which is consistent with our view that these sales will take longer to recover.

Speaker 2

Large case VB sales in particular have a longer sales cycle and are more concentrated around January 1 effective dates. Persistency for our major product lines in Unum US remained in line to higher this quarter relative to the Q1 of 2020, providing a good tailwind for premium growth for the full year and into 2022. We have also seen favorable trends in natural growth in our employee benefit lines, primarily from higher wage growth at this point. Now moving to the Unum International segment, adjusted operating income for the Q2 was $24,800,000 compared to $26,400,000 in the Q1 and $15,100,000 in the Q2 of 2020. The primary driver of these results is in our Unum UK business, which generated adjusted operating income of £16,800,000 in the 2nd quarter Compared to £18,600,000 in the Q1 and £10,100,000 in the Q2 of 2020.

Speaker 2

We are pleased with these results, which showed improved vendor line benefits experience, particularly in our group lifeline. The reported benefit ratio in Unum UK, It showed an increase to 82.5% in the 2nd quarter from 75.3% in the 1st quarter was impacted by Increase in inflation in the U. K. In the 2nd quarter compared to the Q1. Higher inflation triggers higher inflation related benefits to certain of our policyholders as well as higher net investment income from the inflation index linked gilts in our investment portfolio.

Speaker 2

The rapid increase in inflation in the U. K. From the 1st to second quarter did distort somewhat the timing of these two factors and produced a net negative impact slightly less than £3,000,000 to adjusted operating income this quarter. This short term impact to income is expected to balance out over the course of the year. Overall, we are very pleased with results in our international business with benefit ratios adjusted for inflation for Unum UK improving both on a sequential and year over year basis.

Speaker 2

Premium growth for our international businesses was also favorable this quarter compared to a year ago. Looking at the growth on a year over year basis In local currency to neutralize the benefit we saw from the higher exchange rate, Unum UK generated growth of 3% With strong persistency in the ongoing successful placement of significant rate increases on our in force block. Unum Poland generated growth of 12.4%, A continuation of the low double digit growth this business has been producing. With this growth, our Unum International in force premium is now at its highest level. Next, we are very pleased with the results generated by Colonial Life with adjusted operating income of $95,800,000 in the 2nd quarter compared to $73,300,000 in the Q1.

Speaker 2

This record quarterly income level was primarily driven by improved benefits experience And higher net investment income. The benefit ratio improved to 51.7% in the 2nd quarter from 55.4% in the 1st quarter As experience in the life insurance block improved with the overall decline in COVID related mortality. Experience in both the accident, which is primarily driven by higher income from bond calls. Looking out to the Q3, we anticipate adjusted operating income To settle back to the low to mid $80,000,000 range as some of this favorable experience moderates. We're very excited with the rebound in sales activity we're experiencing in Colonial Life this quarter, increasing 53.7% on a year over year basis.

Speaker 2

While this strong recovery comes off of a COVID depressed result in the year ago quarter, this quarter marks a return to year over year growth as face to face sales Reemerge and we drive further utilization of our digital sales and enrollment capabilities. As expected, premium income declined 4 point 3% on a year over year basis and will likely continue with negative comparisons for the next couple of quarters until sales volumes have sufficiently recovered. Persistency for Colonial Life continues to show an encouraging trend at 78.3% for the first half of 2021, almost a point higher than a year ago. Then in the Closed Block segment, adjusted operating income $111,200,000 in the 2nd quarter compared to $97,000,000 in the 1st quarter, both very strong quarters relative to our historical levels of income for this segment. Results this quarter benefited from strong levels of net investment income due to higher levels of miscellaneous investment income, which I'll cover in more detail in just a moment, as well as favorable underlying benefits results in both Long Term Care and the closed disability blocks.

Speaker 2

Looking within the closed block, the LTC block produced a slightly lower interest adjusted loss ratio of 74.6% in the 2nd quarter compared to 77.7% in the Q1, both results quite favorable to our long term expected range of 85% to 90%. Over the past 4 quarters, the benefit ratio for LTC was 70%, excluding the impact of the Q4 2020 reserve assumption update. We continue to see higher mortality experience in the claimant block in the Q2 and estimate that counts were approximately 5% higher than expected. LTC claims incidence was slightly higher in the Q2, though we have seen higher recoveries on many of these claims, which mitigates the financial impact. Looking forward to the second half of the year, we anticipate that the interest adjusted loss ratio for LTC will Likely remains slightly favorable to our long term assumption range as mortality and incidence trends continue to normalize from the impacts of COVID.

Speaker 2

For the closed disability block, the interest adjusted loss ratio was 69.6% in the 2nd quarter 68.9% in the 1st quarter. The underlying experience on the retained block, which largely reflects the active life reserve cohort and certain other smaller claims blocks we retained, Performed favorably to our expectation, primarily due to lower submitted claims. So overall, it was a very strong performance this quarter for the Closed Block segment, driven by both higher miscellaneous income and favorable underlying benefit experience. We estimate the Quarterly operating income for this segment will over time run within the range of $45,000,000 to $55,000,000 assuming more normal trends for investment income and claim results. So wrapping up my commentary on the quarter's financial results, the adjusted operating loss in the corporate segment It was $48,500,000 in the 2nd quarter compared to $38,900,000 in the 1st quarter.

Speaker 2

This excludes the special items we listed in our earnings release. We anticipate that quarterly losses in the corporate segment will moderate in the second half of the year to the low to mid $40,000,000 range. I'd now like to turn to our investment portfolio where we are seeing very favorable overall credit trends. First, There were no downgrades from investment grade securities to high yield this quarter. In fact, we had net upgrades in ratings overall for the portfolio, which generated a small capital benefit to us this quarter.

Speaker 2

In addition, our internal watch list of potential credit concerns It's now lower today than it was coming into the pandemic in early 2020. As you have read in our earnings release and heard through my comments this quarter, We had a very high level of miscellaneous investment income this quarter, which you know is generated from 2 sources. First, We saw a high level of miscellaneous investment income from bond calls again this quarter as many companies look to refinance higher coupon debt and take advantage today's lower interest rates and tight spreads. We had approximately $10,000,000 higher investment income from bond calls this quarter relative to our historical quarterly averages. Over the past several quarters, this has been extremely volatile and difficult to predict from quarter to quarter.

Speaker 2

While these bond calls enhance current period investment income, It is a challenge to replace the lost deals in today's low interest rate environment. 2nd, as I mentioned previously, we continue to see strong performance In the valuation mark on our alternative investment assets, which totaled $51,900,000 in the 2nd quarter, Following a positive mark of $35,900,000 reported in the Q1, both quarters are well above the expected quarterly positive marks on the portfolio of $12,000,000 to $14,000,000 This quarter's very strong returns primarily reflected returns for the period Ending March 30, 2021, due to the lags in reporting typical on many of these investments. The higher returns this quarter were generated from all 3 of our main sectors, Credit, Real Estate and Private Equity and reflect the strong financial markets and strong economic growth. It is hard to predict quarterly returns from miscellaneous investment income, But the Q3 so far, we are seeing a continuation of favorable trends in bond call premiums. Moving now to our capital The financial position of the company continues to be in great shape, providing a significant financial flexibility.

Speaker 2

The risk based Capital ratio for our traditional U. S. Insurance companies improved to approximately 3 75 percent and holding company cash was $1,700,000,000 as of the end of 2nd quarter, which are both well above our targeted levels. During the Q2, we successfully completed a debt offering issuing $600,000,000 Of a 30 year senior note with a coupon of $5.08 This was the lowest coupon on a 30 year debt issue in our history. The proceeds from the issue were used to redeem the $500,000,000 4.5 percent issue that would have matured in 2025 And you'll see the debt extinguishment costs associated with the redemption, including in our net income this quarter.

Speaker 2

Importantly, this transaction enabled us to extend the duration of our debt stack and reduce the overall coupon on our outstanding debt. With the issuance and the redemption completed in the Q2, our leverage ratio currently is 26.2%, providing additional financial flexibility. An important industry development recently was the finalization of the C1 factor changes, which have been under consideration by the NAIC for the past several years. At our outlook meeting this past December, we indicated that our capital plan for 2021 in our capital plan for 2021, We assumed a negative impact of approximately $225,000,000 from the adoption of the factor changes. As you are likely aware, the NAIC concluded By adopting recommendation from Moody's Analytics, which are not as impactful to our capital plan as we previously had assumed.

Speaker 2

We now estimate the impact to our capital position to be less than $70,000,000 rather than the $225,000,000 we had previously projected, A very good outcome for us, which provides upside to our capital expectations for year end 2021. I'll close my comments with an update to our outlook for 2021. Previously, we expected a modest decline of 5% to 6% For full year 2021 after tax adjusted operating income per share relative to the 2020 level of 4 $4.93 per diluted common share. Given the strong second quarter results and our updated view on COVID trends, We are revising our outlook upward and now look for 2021 after tax adjusted operating earnings per share to decline by a range of approximately 1% to 3 relative to 2020. Our underlying performance is expected to remain quite healthy, though COVID and the Delta variant will continue to be an So now I'll turn the call back to Rick for his closing comments and look forward to your questions.

Speaker 1

Great. Thank you, Steve for that summary of our Q2. As you'll hear from the rest of the team, we continue to be very pleased with the operational performance of the company through what has been an extraordinary environment. We believe we are well positioned to benefit from today's improving business conditions and we remain vigilant as the pandemic conditions. We're happy to be taking your questions So let me ask the operator to open up the session.

Operator

Thank you. And we will now begin the question and answer session. We kindly ask that you please limit yourself to one question and one follow-up. And at this time, we'll pause momentarily for the first question. And our first question today will come from Ryan Krueger with KBW.

Operator

Please go ahead.

Speaker 3

Hi, good morning. Could you expand a little bit on your comments about potentially Pre funding the main premium deficiency reserve and give us any sense of the potential timeframe you might look to pre fund it over?

Speaker 1

Sure, Brian. Let me take you back a step though to talk about our overall capital position and capital deployment. I mean, I have to start off first that We come at all of this from a very strong position and the capital we've generated both from how operations have done, but also going back to last year end with the individual disability Reinsurance transaction. So we start from a very strong position. And the first thing, as we've said multiple times, is to put that money, put that generation into the core business.

Speaker 1

So we're very happy. You'll hear about that probably some more this morning. Very happy about how the core business has responded in this environment. So we want to put that money To organic growth and then also have flexibility to do some capability driven acquisitions where we see that opportunity, similar to what we've done over past times. And so Then it takes you forward to what are our options with the excess and we do have excess relative to our expectations.

Speaker 1

You start out with a little bit choppier environment that we see Looking at the PDR, the premium deficiency reserve that we have with the state of Maine. And so we look at that as Something that's an obligation to us over a 7 year period of time.

Speaker 4

It is something we have

Speaker 1

to look at and we think pre fundings a portion of that Might make some sense in today's market. When you think about the pre funding, think about it as well as this is an area which those funds will ultimately need to go to. And it's also addressing one of the bigger concerns that people have about the company today and that's the overhang of our LTC obligation And liability is there. So that's the thought process. I really can't give you any sizing today or timing to that, but certainly That's a thought process that we are in the middle of

Speaker 3

today. Thanks. Just one follow-up. In addition to that, I just wanted to confirm that you are still planning to resume share repurchase near term as well?

Speaker 1

We've not made that commitment, Ryan. And so we will that's an option That's available to us, but we look at that in conjunction with those three options today. And I think in today's environment, is this the right time to be starting up a Share repurchase program, one that we haven't been doing for some time. And we look at all of those options of the excess, including Holding on to the capital is real thing. So we are not committing to anything from a redeployment in the form of share repurchase.

Speaker 1

We certainly remained committed to our dividend and redeploying capital to shareholders in that form, but not on the share repurchase as of today.

Speaker 3

Got it. Thank you.

Operator

And our next question will come from Tom Gallagher with Evercore. Please go ahead.

Speaker 5

Good morning. Rick, just a follow-up to Ryan's question. I guess up until recently you sounded a little more positively inclined on buybacks. And I think the pre funding and everything you've said about LTC makes a lot of sense. But just curious, Why at least the tone change on buybacks?

Speaker 1

Yes. No, I think when you think about it, Tom, and what we're trying to accomplish, We have to look at buybacks as one form and anything we would have contemplated there would have been quite modest. I don't think we've said there will be anything more than that. And So now we're just given the facts that we as we see them today, as we've gone through this summer and the period of time, looking at what's going on in the world around us. Mean, all those are influences.

Speaker 1

No one thing would cause us to change tone around that, but those are all things we put into the mill. So we just want to be very clear that those They're available to us, but we're going to have to make those decisions through the Q3, through the Q4 based on what we're seeing in the environment around us.

Speaker 5

Got you. And then is it should we think about that as really just being driven by macro, The level of rates currently and what's going on with the Delta variant Or is it also more in consultation with rating agencies regulators? You think this would be the more prudent path? Like What's the greater determinant for why you're considering prefunding LTC?

Speaker 1

Yes. So I think all of those that you mentioned are all factors. We want to make sure all of our constituents are thought about through this process. The fact that the Delta variant is Starting, I mean, it really hasn't come through in terms of what we've seen in our books of business that they risk that we have out there. I don't want to overplay That has changed anything in the course of what we're looking at.

Speaker 1

But when you look at the risk of that out there through the next Couple of quarters when you look at interest rates, which have come down pretty precipitously over the course of the summer, those are all factors that play in. But I wouldn't highlight any one factor greater than the other.

Speaker 5

Okay. And if I could just sneak in one more for Steve. The I guess you mentioned you're assuming the favorable trends at Colonial this quarter are expected to fade in the back half of twenty twenty one. Is that because you saw more of a return to normal claims utilization toward the end of the quarter, During the course of the quarter or into during July maybe? Or is that just being more conservative that you're not assuming Continuation of the favorability there?

Speaker 2

Yes, Tom. Good morning. It's Steve here. I would say that kind Low 80s would be more of a normal run rate and second quarter is a bit of an anomaly. We had higher than probably continue into the back half of the year.

Speaker 2

So I wouldn't say that we're in any way kind of regressing. I just think that 2Q is a bit of anomaly And probably the low 80s is just about our long term expectation, which is more consistent with what we've seen in the past.

Speaker 5

Okay, thanks.

Speaker 2

Thanks, Tom.

Operator

And our next question will come from Jimmy Bhullar with JPMorgan. Please go

Speaker 4

ahead.

Speaker 3

Hi, good morning. So first, just had a question on the just your views on what you're seeing on long term care Claim submissions, has activity sort of come back to normal? Or are people still sort of reluctant to visit Nursing homes and stuff, given the delta variant. And obviously, mortality is a tailwind in that product line, but are you seeing anything in terms of claim submissions as well?

Speaker 2

Hey, Jimmy, it's Steve here. I'll take that one. So I'll take us really back to what we've seen over the last 5 quarters. As you know, Q2 of last year, we really saw, I'd say, Three things in our benefits experience. Number 1, extremely high claimant mortality, specifically in nursing home, we are about 30 Higher than our expectations.

Speaker 2

The second thing that we saw was lower than expected claims incidents as people were Potentially reluctant to claim really in any site as whether it's at home or in a facility. And then we also saw really a slowdown of transitions between Fidus, so slowdown of people moving from home care To facilities or vice versa, people pretty much just stayed where they were. What we've seen in those 3 over time, climate mortality continued to be Pretty elevated through the last several quarters, about 15% elevated. We've seen that come down to about 5% elevated In the Q2, we would think that that would continue to moderate. When you think about vaccination trends, pretty targeted towards the older population, which clearly is where our block would be concentrated.

Speaker 2

So we would see that continue to moderate the latter part of the year. From an incidence perspective, we have seen incidence continue to kind of trend up more to our expectations. I would say that's where we are in the 2nd quarter. Maybe a little bit higher incidence, a little bit higher recoveries of those new claimants. But financially, I'd say we're back pretty much to our expectations.

Speaker 2

And then the last would be transitions. And we have seen that open up a little bit, but I'd still say that it's probably a little bit light versus what we might have historically seen pre pandemic as far as people moving We've seen pre pandemic as far as people moving between different sizes. So I'd say we're getting back to normal. We'll have to see what this next wave of delta variant does within the block and how that affects those different dynamics. But we do think That will be trending back to kind of that 85% to 90% range, probably at this point by the latter part of the year in the next year.

Speaker 3

Okay. And then on the Colonial, just it seems like you're fairly constructive on an uptick in sales given sort of The return of face to face people getting back to work. Do you think that recovery could be pushed back given that COVID cases have been picking up recently and some of the companies that had planned on having their employees back at work are pushing the timing of that back as well. But just any comments on what you've seen in terms of sales activity in Colonial recently and how that's affected by increasing cases?

Speaker 1

Yes, Jimmy, we are very pleased with the resilience of that franchise. I'll turn it over to Tim Arnold to talk about some of the dynamics that we're seeing and how we're thinking about

Speaker 6

it going forward. Thanks, Jimmy. Appreciate the question. So, we are seeing really strong activity levels in all geographies. We're seeing strong results Across industry segments and across product categories, we have tremendous agent retention.

Speaker 6

We currently have 19% more agents than we have at the same time. In 2019, we're seeing great engagement among our agents and tremendous productivity. We're finding that technology paired with a really Strong agency distribution force is the key to being successful in this environment where we can enroll and provide benefits education under virtually any scenario. We are seeing a substantial increase in virtual enrollments. But what we're also seeing is that even in states where there are high levels Of the Delta variant, we're not seeing a return to the kind of shutdowns that we saw in 2020.

Speaker 6

And so we believe that we'll be able to continue with Face to face enrollments and also augment those with the incredible digital tools that we've built over the last few years.

Speaker 3

Okay. Thank you.

Speaker 2

Thanks, Jimmy.

Operator

And our next question will come from Don Thrupp Lee with Dowling and Partners. Please go ahead.

Speaker 4

Hi. Thank you for taking my questions. My first question is related to Group Life and AD and D. You talked about 800 excess claims In the quarter with average claim size of 55,000, that would mean kind of roughly $44,000,000 $45,000,000 of excess Claims in the quarter and that will put your normalized earnings kind of for the quarter closer to $50,000,000 which are still quite low compared to what I was just wondering besides COVID, what else is driving the depressed earnings for the segment?

Speaker 2

Yes. Humphrey, I'll take that. This is Steve. I'm not completely following your math, but I'll just kind of restate What our assumptions are and how we're thinking about the last half of the year. In the Q2 of 'twenty one, we did have about 800 what Estimated 800 COVID related deaths and that was on a nationwide count of 52,000.

Speaker 2

I would say It's kind of hard to do a rule of thumb calculation anymore just because we are seeing a different population in our experience As COVID starts to impact the kind of younger, more working aged individuals, so we have that 1% kind of rule of thumb, that's drifted up quite a bit. It's probably around 1.5% at this point. We do anticipate in the 3rd quarter And really in the Q4, a nationwide level of about 40,000 COVID related deaths. And so if you kind of run the math Through what we think the distribution of that's going to be, we do think earnings will probably be around $15,000,000 for both 3rd and 4th quarter. Now as far as just the broader kind of historical levels of earnings and that sort of thing, we do see fluctuations Quarter to quarter, just in the average size and the count of claims that was pretty consistent between Q1 and Q2, but that can fluctuate Quite a bit period to period.

Speaker 2

I think what we just need to see is kind of get through this uncertainty of pandemic and then kind of rebaseline What the earnings power of the Group Life business is, but we continue to feel really good just about the premium levels there and how that's resonating with the market. So Probably more to come as we get into looking into next year.

Speaker 4

Okay, got it. On the positive side, You talked about seeing some benefits of wage growth coming through. Can you size the uplift that you're seeing and then as well as your kind of forward expectation?

Speaker 1

Hey, Humphrey, it's Mike. I think I can take that. The question is about natural growth and what's coming through in the client base. And you are right, we've started to see that Ticked up a bit and on the backs of wage growth and not yet Seeing the employment side of that equation come through. So should economic expansion continue, should the labor market Continue to improve that would represent a bit of upside for us, particularly in the group insurance lines.

Speaker 4

Okay. Thank you.

Speaker 2

Thanks Humphrey.

Operator

And our next question will come from Tracy Banquigwe with Barclays. Please go ahead.

Speaker 7

Good morning. Could you confirm my understanding any PDR prefunding, would that be voluntary? And Maine does not require you to accelerate 7 year timeline if you hold excess capital?

Speaker 1

Yes. The way we're looking at that, Tracy, is it would be voluntary. This is just something we're looking at. Like we said, it's an Obligation over the next 7 years, going back a year. And so we would be it would be voluntary and what form we put that in and timing, That is up to us.

Speaker 1

We're still maintaining, moving along the path of the original TDR.

Speaker 7

Okay, great. I think you're also suggesting that any potential LTC Block transaction may be contingent upon prefunding PDR. And I guess I'm just wondering if it's like a modco or funds withheld structure, why that would matter?

Speaker 4

Yes. So no, that's not what

Speaker 1

we're saying. I think what we're saying is as we put more Funds to our long term care business ultimately in a transaction that will get realized. So it's not the technical nature of it in terms of how a transaction Done and how it moves around. It's just saying that the more funding we have behind our long term care block, ultimately what a buyer when they look at it, there'll be a smaller gap now In that period of time. So it's nothing technical, just saying there's more capital that's now within the LTC business, which would then be realized upon sale.

Speaker 7

Okay. Thank you.

Operator

And our next question will come from Erik Bass with Autonomous Research. Please go

Speaker 8

ahead. Hi, thank you. Maybe first just to follow-up on Tracy's question, I guess, has anything changed in terms of what you're seeing in terms LTC risk transfer market and just the appetite for blocks?

Speaker 4

Yes, maybe I'll step back

Speaker 1

in that little bit, Eric. I mean, when you think of the prospects that we've talked about of an LTC transaction, I think that from our Perspective, going back to last year end, certainly, we feel like we have the capabilities to do so. Our IDI transaction is a good indicator of that. We now see it a little bit differently that we can actually perhaps customize some of the risk that a counterparties willing to take on. I'll tell you what has changed and which is just part of the dynamics of the market is just where interest rates are.

Speaker 1

We've talked about that as being a headwind To any type of transaction and widening the gap, and those certainly have come down here over the last quarter. So that's probably the only thing that has changed. That's the math of the deal, but I don't think any other dynamics have really changed to how we've talked about it recently.

Speaker 8

Got it. Thank you. And then can you talk a bit about activity levels and competitive dynamics in the U. S. Group market and how are these Kind of feeding into your sales outlook for the second half of the year?

Speaker 8

Sure, Eric.

Speaker 1

It's Mike. I could take that. It might be a good opportunity to talk a little bit about Our different geographies because we are encouraged on a broad basis about the recovery and you see that quarter over quarter as Wolfrik and Steve highlighted in their remarks. In the group insurance market to your specific question, we are encouraged About activity levels and what's coming through in the pipeline, the competitive realities are not terribly dissimilar from what we've seen In prior periods, I do think, while no one carrier really stands out as being overly aggressive, I think there are a number of Players out there that are probably looking to make up for some lost ground after a challenging 2020, we're going to stick to Pricing and underwriting guidelines, but are again pretty encouraged about the ability to differentiate on things like our investments in leave And our HR Connect capability has put us in that I think pretty good stead. We'll play opportunistically in that large case market where I'd say the competition is Probably the toughest.

Speaker 1

If you go down market and it's literally almost linear down into the small case market, things are really opening up and we are encouraged. Core overall was up in the quarter. And if you go down into the small end of core, we are seeing nice double digit increases there, which bodes well for us. Going forward, I think, Tim, maybe comment a little bit on the competitive market and what you're seeing in line with that?

Speaker 6

Yes. As I mentioned earlier, we're Very encouraged by the activity levels we're seeing, by the results we have in the Q2. We're very encouraged by the early trends we're seeing in the Q3. Similar to Mike's comments, we see tremendous opportunity across both brands. In the core and midsized markets, we do view large case a bit more As well on the BB side, but again very encouraged about the prospects over the second half of the year.

Speaker 1

Great. Yes, Mark, maybe you can hit What you're seeing in the international market?

Speaker 9

Yes. I mean, we're seeing generally buoyant economies in both Poland and the U. K. Such Quarter on quarter, certainly in dollar terms, sales are up 24%. I would say the U.

Speaker 9

K. Market Competitively is very similar, but with hardening of rates, which is encouraging. In Poland, We're seeing some competitor consolidation, but where the focus is on cost reduction, not on market penetration.

Speaker 4

And actually, that distraction should be helpful

Speaker 9

to us, both in terms of talking to Should be helpful to us both in terms of talking to clients and potentially for some staff recruitment ourselves. So I think we're feeling pretty confident.

Speaker 8

Perfect. Thank you.

Speaker 1

Thanks, Eric. Thanks, Eric.

Operator

And our next question will come from Josh Shanker with Bank of America. Please go ahead.

Speaker 10

Yes. Thank you very much. So I'm looking at wonderful results in the Closed Block relative to the past and trying to figure out what's trendable versus what is unusual. I mean, first on the LTC Seaside, obviously, COVID has created some positive headwinds. Are we looking for a reserve Study to conclude about the frequency trends in LTC before we know the impact

Speaker 2

and when we

Speaker 10

look at the numbers, Should we expect what we saw this quarter persist pending a more in-depth analysis of the impact on COVID on LTC?

Speaker 2

Yes, this is Steve. I'll take that one and there's a lot in there. So let me try to break it down a little bit as far as kind of non trendable items. And I'll just start with As I mentioned, from an incidence perspective, we're pretty much back to what our expectations would be. Claimant mortality is still running a little high.

Speaker 2

So you can kind of think about from where we were from a loss ratio perspective in the 2nd quarter, over the next few quarters into next year that will trend back into that 85% to 90% range. Then the other thing that I guess I'd focus on is just net investment income and specifically our miscellaneous net investment income. Overall, we had about $52,000,000 of alternative asset income during the period. The majority of that's going to be in the closed lock. Our expectation would be more in the 12% to 14%.

Speaker 2

So that variance you can pretty much consider a little bit unique and Probably won't recur. Now with that said, this tends to be pretty volatile as far as the marks on this portfolio. So Over time, our expectation is kind of that 12% to 14%, but it can be a little bit higher, a little bit lower. And then the other would be bond calls. And I would say, overall, we were probably for the organization to be $10,000,000 over our expectation overall and maybe half or a little bit less than half of that Would have been in the closed block.

Speaker 2

So you kind of boil that all up and we're looking to the back half of the year to probably be kind of in that $50,000,000 all in closed block earnings for the 3rd and the 4th quarter. But as you know, things can be very volatile in Business line both from a claims experience perspective as well as from Miss Lance net investment income. Now your question about just taking into consideration our claims And I'll add in there our mortality experience into how we think about reserve adequacy and kind of our assumption review. We're really viewing all of what's happened over the last year as an anomaly by and large unless we do see more permanent Changes in behavior and in those types of things. But we're kind of treating this all as an anomaly.

Speaker 2

Feel good about the liability assumptions We have it in our reserve and we'll go through our normal process at year end, but we're not seeing anything right now that would have us change our perspective there.

Speaker 10

And then on the individual disability portion, the lower claims submission, by phrasing that way like that is that unusual? Is that Over the related, is that a change in the nature of the book? Again, just trying to figure out what's trendable in that?

Speaker 2

Yes, yes. So for that closed block IDI, Really two things happened when we did our transaction with Global Atlantic. One was we ceded the majority of our claims blocked to them, But we do still retain some smaller pieces of that block. So we will continue to have some claim it's basically claim termination risk, whether it's mortality or recovery. We still do have a bit of that risk, but that's been pretty consistent with our expectations.

Speaker 2

We also retain the entirety of the active life reserve block. And so if you think about the risk there, It's really incidents on the active lives and then how that claim performs over time. And we have actually seen some pretty favorable Experience around incidents over the last couple of quarters. Again, that can be somewhat volatile. So I would just think About $5,000,000 a quarter for the closed block disability business over the latter half of the year.

Speaker 2

Again, We're kind of new to that block and what we have left and clearly because it's a smaller block, it will probably be more volatile than what we saw when we retained the entire block. But I think just for modeling purposes that $5,000,000 a quarter is a pretty good number.

Speaker 10

And then just to put a bow on it, just to understand, in Q1, what day did the change incept based on the Global Atlantic transaction? When did the transfer occur on which day?

Speaker 2

Yes. Well, there was 2 phases of it. So, I'll take you back to Q4 of last year. We closed for GAAP purposes, the effective date was basically halfway through December. It was when we closed the deal.

Speaker 2

And so the way to think about that We pretty much had the full block in our Q4 financial results. And then that would have been reflected on Phase 1, reflected in our Q1, Q2 results. For Phase 2, that would have been effective really at the end of the Q1. And so, we really closed Phase 2 in the latter part of the So, Q2 was the Q1 we would have reflected Phase 2. And the way to think about it is that second Quarter is pretty much the block we're going to have going forward.

Speaker 2

Just to kind of summarize all that.

Speaker 10

Fantastic. Thank you for all the answers.

Speaker 1

Yes. All right, Josh. Thank you. Thank you.

Operator

And our next question will come from Mark Hughes with Truist. Please go ahead.

Speaker 2

Yes. Thank you. Good morning. Sorry if I missed this earlier. Do you have any comments on the recoveries in the Unum US Group disability line, any change in behavior at the Social Security Administration around Approving disability claims that might be noteworthy.

Speaker 1

Sure, Mark. It's Mike. I appreciate the question. To the first part of it, Recoveries continue to be solid to favorable relative to our expectation. We've built A good deal of expertise into the folks that work with claimants, the clinic and the book staff and That's proved to be a really helpful asset for our clients and for us through the period and really rock solid.

Speaker 1

Second part of your question, you mentioned SSDI and it can move around a little bit. We have seen a little bit of a Slow down, it seems as though the working from home may have created a bit of a backlog. I wouldn't put too much of an emphasis On it at this point, because it does move around. Also, we're aware of some pretty significant increases in approved staffing for the Staff at SSDI. So we stay close to that inventory.

Speaker 1

We've got a couple of partners that we use externally that help us Keep that inventory moving through. It was a little bit of a pressure point in the quarter, but probably too early to call a trend.

Speaker 3

Thank you.

Speaker 1

Sure.

Operator

And our next question will come from Tracy Banquiglia with Barclays, please go ahead.

Speaker 7

Thank you for taking another question. I just want to make sure I'm thinking about your outlook update correctly. Just recognizing that you've had a pretty strong second quarter, is this

Speaker 9

more right size than this year?

Speaker 1

I'm Tracy, you cut out here for in the middle of that question. If you could please repeat the question.

Speaker 7

Sure. Yes, I'm just trying to make sure I understand the outlook update guidance A little bit better. So I think just looking at the Q2, just given your results with higher VII, I'm wondering if the guidance is more rightsizing what we've seen in the first half of the year or are you really thinking about Better performance in the second half, just trying to do the math on getting to your projected results relative to last year.

Speaker 2

Tracy, this is Steve. I can take that one. So, just to reground, our original guidance that we came out with in December of last year was down 5% to 6% in operating EPS year over year. We've adjusted that to down 1% to 3%. I would say there's 2 offsetting factors.

Speaker 2

One is We performed in the Q2 well over our expectation that would have been in that 5% to 6% down. So consider that kind of tailwind to the year over year compare. But then what we've done is we've changed our expectations for the back half of the year really in two places. The most significant one is we have increased our expectation of both nationwide COVID mortality and then how that plays through our book. So that's probably the most significant change to our outlook.

Speaker 2

So We give a little bit of the 2nd quarter performance back there. And then the other thing is just looking at STD volumes, lead volumes due to the Delta variant. We do think that the group disability loss ratio is going to stay elevated kind of where it is right now, probably for the remainder of the year. And therefore, That does dampen our earnings expectation that we would have had in our original guidance just a bit and that So kind of backs off a little bit of the over performance in the second quarter. And so those are kind of the headlines on how we're thinking about it.

Speaker 7

Thank you.

Speaker 1

Great. Thanks, Tracy. I think we're up on time. I'd like to thank everybody for joining us this morning. I hope you hear, there's a lot of Optimism in the team as we look to the second half of the year, and we'll certainly take you through that as we go through it.

Speaker 1

So that now completes our Q2 earnings Operator, I appreciate everybody joining us and we will talk to you soon. Thank you.

Operator

And ladies and gentlemen, the conference has now concluded.

Powered by Quartr
Earnings Conference Call
Unum Group Q2 2021
00:00 / 00:00